Supar Health ApS: Financial statements 2022
CVR: 41298790
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
Supar Health ApS (CVR 41298790) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 0. Equity in the 2022 report amounted to DKK 40,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 0
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
Official annual report
Keep an eye on Supar Health ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Supar Health ApS has published its interim report for the period April 16, 2020 to September 30, 2021.
About Supar Health ApS
Supar Health ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Aetas ApS. The management consists of Thomas Gielsgaard Hargreave. The company is owned by Aetas Healthcare ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -332,648 and a net result of DKK -332,474 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -297,658.
